Massimo Guidoboni

15.6k citations
86 papers · 3.3k · 1 hit paper · h-index 25

Impact in

  • Oncology top 1%
    • Cancer Immunotherapy and Biomarkers
    • Viral-associated cancers and disorders
    • CAR-T cell therapy research
    • Colorectal Cancer Treatments and Studies
    • Lymphoma Diagnosis and Treatment
    • Genetic factors in colorectal cancer

Papers in

    • Cancer Immunotherapy and Biomarkers 23
    • CAR-T cell therapy research 13
    • Viral-associated cancers and disorders 7
    • Immunotherapy and Immune Responses 23
    • Immune Cell Function and Interaction 8

Massimo Guidoboni

83 papers receiving 3.2k citations

Massimo Guidoboni's Hit Papers

Baseline neutrophils and derived neutrophil-to-lymphocyte ratio: prognostic relevance in metastatic melanoma patients receiving ipilimumab 2016 · 315 citations
3150+3+6Years since publication100200300

Peers

Massimo Guidoboni
Comparison fields: 5 of 96
  • Oncology 1.8k
  • Pathology and Forensic Medicine 1.1k
  • Immunology 796
  • Genetics 231
  • Dermatology 145
Replace Fumiko Arakawa with:
Fumiko Arakawa Japan
Leonardo Flenghi Italy
Kirit M. Ardeshna United Kingdom
Katrin S. Reiners Germany
TM Grogan United States
Bernard Mariamé France
Joost J. Oudejans Netherlands
Neil L. Berinstein Canada
Horst Dürkop Germany
Sandeep S. Davé United States
Massimo Guidoboni relative to Fumiko Arakawa Japan Fumiko Arakawa's profile →
Citations per field
00.5×1.5×2.1×
Fumiko Arakawa · 1×
Citations per year

Countries citing papers authored by Massimo Guidoboni

Since Specialization
Citations

This map shows the geographic impact of Massimo Guidoboni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Massimo Guidoboni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Massimo Guidoboni more than expected).

Fields of papers citing papers by Massimo Guidoboni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Massimo Guidoboni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Massimo Guidoboni. The network helps show where Massimo Guidoboni may publish in the future.

Co-authors

The 25 scholars most cited alongside Massimo Guidoboni, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Massimo Guidoboni Line = papers co-authored together Massimo Guidoboni links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 86 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2004386
2 1999382
3
Baseline neutrophils and derived neutrophil-to-lymphocyte ratio: prognostic relevance in metastatic melanoma patients receiving ipilimumab
Hit paper breakdown →
2016315
4 2001276
5 2009227
6 2005152
7 2006146
8 2008119
9 2007105
10 201498
11 202064
12 200561
13 201358
14 200856
15 200654
16 201245
17 202143
18 200535
19 200631
20 200530

About Massimo Guidoboni

Massimo Guidoboni is a scholar working on Oncology, Immunology, Molecular Biology, Pathology and Forensic Medicine and Organic Chemistry, having authored 86 papers that have together received 3.3k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (23 papers), Cancer Immunotherapy and Biomarkers (23 papers), Melanoma and MAPK Pathways (14 papers), CAR-T cell therapy research (13 papers), Lymphoma Diagnosis and Treatment (10 papers), Immune Cell Function and Interaction (8 papers), Viral-associated cancers and disorders (7 papers) and Click Chemistry and Applications (6 papers). The work is most often cited by research in Oncology (1.8k citations), Pathology and Forensic Medicine (1.1k citations), Immunology (796 citations), Genetics (231 citations) and Dermatology (145 citations). Massimo Guidoboni has collaborated with scholars based in Italy, United States and France. Frequent co-authors include Riccardo Dolcetti, Claudio Doglioni, Mauro Boiocchi, Maurilio Ponzoni, Antonia Anna Lettini, Michele Maio, Alessandra Viel, Ettore Macrì, Andrés J.M. Ferreri and Antonio Russo. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Melanoma Research, Clinical Cancer Research and Journal of Translational Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact